U.S., July 9 -- An application to own the trademark for 'OBLAYZO' has been filed on Dec. 18, 2024.
Owner(s):
Takeda Pharmaceuticals International AG; Thurgauerstrasse 130, , SWITZERLAND
Goods and/or Services:
For: Pharmaceutical preparations for the treatment and management of the central nervous system conditions; pharmaceutical preparations for the treatment and management of sleep disorders.
Class(es): 005, 006, 018, 044, 046, 051, 052
Mark Drawing Type: 4 - STANDARD CHARACTER MARK
https://eog-tmng.uspto.gov/#/issueDate=2025-07-08&serialNumber=98910513
Disclaimer: Curated by HT Syndication....